Skip to content
WeighLab

Kin Meds vs Brello Health

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Kin Meds

Provider comparison

Readers comparing compounded entry prices with branded prescribing who will confirm their dose-specific bill and state eligibility.

Semaglutide / month
$199/moStarting (30-day compounded injection; dose-specific quote to confirm)
Tirzepatide / month
$249/moStarting (30-day compounded injection with B12; dose-specific quote to confirm)
Index 65/100 · Grade CChecked October 2026

Brello Health

Provider comparison

Shoppers comfortable with a mandatory 3-month auto-renewing commitment in exchange for a discounted per-month rate.

Semaglutide / month
$133/mo3-month plan, compounded
Tirzepatide / month
$166/mo3-month plan, compounded; a 6-month plan averages $149/mo
Index 64/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Kin Meds has the higher Cost-Efficiency Index: 65/100 versus 64/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Kin Meds
Coverage not published
Brello Health
40 states + D.C.

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Kin Meds

Brello Health

Semaglutide / month
Kin Meds: $199/moStarting (30-day compounded injection; dose-specific quote to confirm)
Brello Health: $133/mo3-month plan, compounded
Tirzepatide / month
Kin Meds: $249/moStarting (30-day compounded injection with B12; dose-specific quote to confirm)
Brello Health: $166/mo3-month plan, compounded; a 6-month plan averages $149/mo
Semaglutide / year (modeled)
Kin Meds: $2,388
Brello Health: $1,596
Tirzepatide / year (modeled)
Kin Meds: $2,988
Brello Health: $1,992
State availability
Kin Meds: Coverage not published
Brello Health: 40 states + D.C.
Oral / sublingual option listed
Kin Meds: Yes
Brello Health: Not listed
Brand-name access listed
Kin Meds: Yes
Brello Health: Not confirmed
Provider facts checked
Kin Meds: October 2026
Brello Health: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Kin Meds

Readers comparing compounded entry prices with branded prescribing who will confirm their dose-specific bill and state eligibility.

Reasons to consider it

  • Current medication pages publish compounded starting prices
  • Names Rush Pharmacy and Strive Pharmacy as dispensing partners
  • Lists branded Wegovy, Zepbound and Foundayo with the separate consultation fee disclosed

What to weigh up

  • Compounded rates are starting prices; a complete dose-specific ladder is not published
  • Brand-name plans start at $149 monthly for consultation alone, with medication billed separately
  • No treatment-specific state list or individual medical director is published

Regulatory note: the FDA issued a warning letter to Kin Meds in February 2026. We still list and link to Kin Meds; you should know the letter is on the public record before you decide.

Brello Health

Shoppers comfortable with a mandatory 3-month auto-renewing commitment in exchange for a discounted per-month rate.

Reasons to consider it

  • Discount structure is itemized transparently — both the discounted and pre-discount standing price are shown side by side ($133 vs $198 for semaglutide, $166 vs $247 for tirzepatide)
  • Bundle options combining GLP-1 with NAD+ and/or Sermorelin are available on the same subscription
  • Spells out the commitment on its site ('3-month minimum commitment and automatically renew every 11 weeks') rather than burying it in the terms

What to weigh up

  • No month-to-month option at any price: the 3-month plans renew every 11 weeks, and the 6-month tirzepatide plan bills $894 every 22 weeks and ships in two boxes about 11 weeks apart
  • The compounding pharmacy is not named, only 'USA-based 503A Partner Pharmacy,' and the site discloses it is mid-transition to a new facility
  • No named medical director or individual prescriber, only 'a healthcare provider reviews your information'

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Kin MedsBrello Health
Normalized Cost/Month
Kin Meds:
64/100
Brello Health:
60/100
Price Transparency
Kin Meds:
92/100
Brello Health:
78/100
Nationwide Access
Kin Meds:
24/100
Brello Health:
66/100
Formulation Options
Kin Meds:
95/100
Brello Health:
66/100
Clinical Oversight
Kin Meds:
62/100
Brello Health:
80/100
Contract Flexibility
Kin Meds:
55/100
Brello Health:
20/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.